the specific objectives of this funding opportunity are:

• to support planning activities, partnership development and to increase understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of cihr; and
• to support dissemination events and activities that focus on the communication of health research evidence to the appropriate researcher or knowledge-user audiences, tailoring the message and medium as appropriate

the specific objective of this funding opportunity is:

• to facilitate multinational, collaborative research projects that will address important questions related to sensory disorders and their impact on the nervous system. they may include research into all the sensory modalities including the somatosensory system and research questions addressing synergies across modalities and multisensory dysfunction.

the operating grants competition is the principal means by which the cancer research society (crs) fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease. this program allows for the awarding of seed money to the most promising canadian researchers who submit original projects related to various aspects of cancer. this investment builds on a previous partnership with crs, and aligns with cihr-icr’s strategic plan while also promoting the funding of early career researchers (see eligibility). this partnership also allows cihr-imha to target funds to support skin research in the area of non-melanoma skin cancers.

research areas

this funding opportunity will support projects relevant to the following research areas:

• breast cancer
• all other cancer research
• non-melanoma skin cancers

the canadian frailty network (cfn) is looking to fund knowledge translation and real-world implementation proposals aimed to empower remote indigenous communities to enable them to improve care for, and support their elders to remain in their home or communities. cfn will only fund proposals that are co-created/co-designed in close partnership with indigenous community members. proposals must focus on the scale or spread of a prior health and/or social care initiative shown to be effective in a smaller context.

neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. worldwide, there are an estimated 47 million people suffering from alzheimer’s disease and related disorders, the most common class of neurodegenerative diseases. existing treatments for neurodegenerative diseases are limited in effect and mainly address the symptoms rather than the cause or the progressive course. the eu joint programme - neurodegenerative disease research (jpnd) was established to better coordinate research efforts across countries and disciplines to find causes, develop cures, and identify better ways to care for people with neurodegenerative diseases more rapidly. to identify research priorities, the jpnd research and innovation strategy, published in 2019, provides a framework for future investments.

recent years have seen major increases in the range and power of technologies across the basic, clinical and patient-centred domains of jpnd. the use of imaging and analysis technologies has become more sophisticated, and the use of brain stimulation techniques has increased. these techniques help to better understand, treat or diagnose neurodegenerative diseases, but there is still a need to assess the potential of these approaches to deliver new and better treatment options for these debilitating diseases.

the goal of this joint transnational call is to promote research aiming at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.

proposals to be funded under this call will need adequately to involve patients, caregivers and the public. consortia are expected to make every effort to include approaches on patient and public involvement, where appropriate, at each stage of the research process including the preparation of the application.

for more information, please consult the eu joint programme – neurodegenerative disease research (jpnd).

enable researchers in rare diseases involved in an interdisciplinary research project to capitalize on complementarities and sharing of expertise, with a clear translational research outcome and clinical impact.

cira aims to increase the number of canadians who have access to a high-quality and high-performing internet.

we fund connectivity research, core infrastructure, last-mile connectivity services and operational solutions that increase performance, lower costs and improve data sovereignty.

nmin’s strategic initiative (si) program focuses on supporting just-in-time research development, commercialization and knowledge mobilization/transfer opportunities that arise in-year and/or require a rapid response in order to generate, promote or accelerate the economic and social benefits of previous or new nmin or related research investments. these funds are intended to provide support for research, post-discovery commercialization, business planning and knowledge dissemination, mobilization, or translation activities. the projects must be scaled to be achievable within a one-year/12-month timeframe and be aligned with nmin’s mission and vision. ideally, the si will be undertaken in partnership with nmin partners, stakeholders, and/or end-user organizations.